Ribomic (TSE:4591) Total Liabilities : 円108.56 Mil (As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Ribomic Total Liabilities?

Ribomic's Total Liabilities for the quarter that ended in Sep. 2024 was 円108.56 Mil.

Ribomic's quarterly Total Liabilities declined from Dec. 2023 (円201.23 Mil) to Mar. 2024 (円155.81 Mil) and declined from Mar. 2024 (円155.81 Mil) to Sep. 2024 (円108.56 Mil).

Ribomic's annual Total Liabilities declined from Mar. 2022 (円260.53 Mil) to Mar. 2023 (円199.30 Mil) and declined from Mar. 2023 (円199.30 Mil) to Mar. 2024 (円155.81 Mil).

Ribomic Total Liabilities Historical Data

The historical data trend for Ribomic's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ribomic Total Liabilities Chart

Ribomic Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

88.79

116.96

260.53

199.30

155.81

Ribomic Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24
Total Liabilities	Get a 7-Day Free Trial															197.27	144.89	201.23	155.81	108.56

Ribomic Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Ribomic's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	155.81	+	(0	+	-0.0010000000000048
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	155.81

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	3547.257	-	3391.448
	=	155.81

Ribomic's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	108.555	+	(0	+	0.00099999999999056
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	108.56

Total Liabilities	=	Total Assets (Q: Sep. 2024 )	-	Total Equity (Q: Sep. 2024 )
	=	3394.628	-	3286.072
	=	108.56

Ribomic Total Liabilities Related Terms

Thank you for viewing the detailed overview of Ribomic's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Ribomic Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ribomic Inc (TSE:4591) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-16-13 Usui Building, Shirokanedai, Minato-ku, Tokyo, JPN, 108-0071

Website

http://www.ribomic.com

Ribomic Inc is a biopharmaceutical venture company based in Tokyo. The company is developing molecular targeted pharmaceutical drugs using RNA aptamers with its unique and advanced platform technologies, the RiboART System.

Ribomic Headlines

No Headlines